The results demonstrated that altering OTULIN expression alone did not alter the proliferative capacity of osteosarcoma cells but that OTULIN deficiency significantly reduced the resistance of osteosarcoma to cisplatin. This evidence concerns the gene OTULIN and osteosarcoma.